Can You Use Vascepa Rebate with Insurance?
Yes, you can typically use the Vascepa Savings Card (rebate program) alongside insurance, including commercial plans, Medicare, and Medicaid.[1] It reduces your out-of-pocket costs for icosapent ethyl (Vascepa) by covering the difference between your copay/coinsurance and a maximum monthly savings—up to $75 for commercial insurance or $15 for government plans, with annual caps of $900 or $180.[1][2]
Eligibility requires a valid prescription, U.S. residency, and enrollment via the card from VascepaSavings.com. The pharmacy processes insurance first, then applies the rebate at checkout.[1]
What If You Have No Insurance or High Deductibles?
Uninsured patients or those in the coverage gap pay as little as $9 per 30-day supply (up to 12 fills yearly).[1] High-deductible plans work similarly, but confirm with your pharmacy, as some restrictions apply during the deductible phase.[2]
How Does It Work with Medicare or Medicaid?
Medicare Part D and Medicaid patients qualify for a modified rebate ($15 max monthly, $180 annual), but it excludes long-term care facilities.[1][3] Check Medicare plan rules, as some formularies cover Vascepa with prior authorization.
Common Restrictions and Exclusions
- Not for cash-paying patients without trying insurance first.[1]
- Excludes 90-day supplies in some cases; max 30- or 60-day fills.[2]
- Cannot combine with other Vascepa offers.[1]
- Expires if coverage changes; re-enroll as needed.
Who Makes Vascepa and Runs the Rebate?
Amarin Pharma manufactures Vascepa. The rebate is administered through a third-party like ConnectiveRx.[1]
Vascepa Patent Status and Cost Factors
Vascepa's key patents expired in 2020 for some uses, but method-of-use patents extend protection, delaying generics until at least 2026 (pending litigation).[4] This keeps list prices high (~$300/month), making rebates essential.[4] Track updates on DrugPatentWatch.com.
[1]: VascepaSavings.com official savings card terms
[2]: GoodRx Vascepa savings details
[3]: Medicare.gov coverage for Vascepa
[4]: DrugPatentWatch.com - Vascepa patents